GlassScriptPhysician profile
Michelle L Howell
NPI 1427081348
$2,421.72
in general payments reported to CMS, 2019-2025
18 companies · $390 in 2025
The $390 reported for 2025 was more than what a typical Optometrist provider received nationally (typical 2025 total: $204).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $280 · 2020: $209 · 2021: $765 · 2022: $268 · 2023: $190 · 2024: $320 · 2025: $390.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $900.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $900.20 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Coopervision INC. | $818.73 | 2019-2025 | Myday Contact Lens, Clariti Contact Lens |
| Bausch & Lomb Americas INC. | $624.37 | 2022-2025 | Miebo, Xiidra, Infuse |
| Bausch & Lomb, A Division of Bausch Health US, LLC | $268.89 | 2019-2021 | |
| Kala Pharmaceuticals, INC. | $143.47 | 2021-2022 | |
| Alcon Vision LLC | $108.72 | 2020-2023 | Precision 1 |
| Shire North American Group INC | $92.86 | 2019 | |
| Johnson & Johnson Vision Care, INC. | $74.08 | 2021-2025 | |
| Sun Pharmaceutical Industries INC. | $47.68 | 2021-2023 | Cequa |
| Tarsus Pharmaceuticals, INC. | $43.47 | 2025 | Xdemvy |
| Oyster Point Pharma, INC. | $39.64 | 2022 | |
| Thea Pharma INC. | $32.27 | 2024-2025 | Iyuzeh |
| Allergan, INC. | $25.56 | 2022 | |
| Abbvie INC. | $23.53 | 2022 | |
| Astellas Pharma US INC | $17.87 | 2025 | Izervay |
| Abb Con-Cise Optical Group LLC | $16.56 | 2024 | Spectacle Lenses, Contact Lens |
Show all 18 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Visioneering Technologies, INC. | $15.41 | 2022 | |
| Harrow Eye, LLC | $14.75 | 2024 | Vevye |
| Carl Zeiss Meditec, INC. | $13.86 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Michelle Howell listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.